Cargando…
Subgroup analyses in confirmatory clinical trials: time to be specific about their purposes
BACKGROUND: It is well recognized that treatment effects may not be homogeneous across the study population. Subgroup analyses constitute a fundamental step in the assessment of evidence from confirmatory (Phase III) clinical trials, where conclusions for the overall study population might not hold....
Autores principales: | Tanniou, Julien, van der Tweel, Ingeborg, Teerenstra, Steven, Roes, Kit C. B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4757983/ https://www.ncbi.nlm.nih.gov/pubmed/26891992 http://dx.doi.org/10.1186/s12874-016-0122-6 |
Ejemplares similares
-
Level of evidence for promising subgroup findings in a negative trial
por: Tanniou, Julien, et al.
Publicado: (2013) -
Sample size calculations in pediatric clinical trials conducted in an ICU: a systematic review
por: Nikolakopoulos, Stavros, et al.
Publicado: (2014) -
Beyond “Intent‐to‐treat” and “Per protocol”: Improving assessment of treatment effects in clinical trials through the specification of an estimand
por: Pétavy, Frank, et al.
Publicado: (2020) -
An Application of Sequential Meta-Analysis to Gene Expression Studies
por: Novianti, Putri W, et al.
Publicado: (2015) -
14th Annual University of Pennsylvania Conference on statistical issues in clinical trials/subgroup analysis in clinical trials: Opportunities and challenges (morning panel discussion)
por: Roes, Kit, et al.
Publicado: (2023)